금융 뉴스 허브
실시간 글로벌 금융 시장 뉴스 · 분석 · 인사이트
BREAKING주요 뉴스
Oil Traders Stay Bearish Despite Deepening Middle East Disruptions
Despite continued hostilities in the Middle East and an expansion of the war to the Red Sea, oil tra...
EU Locks In Plan To Triple Energy Storage Capacity By 2030
Europe desperately needs an energy storage revolution. As the region gets rocked by the third energy...
S&P closes at record high as soft jobs report eases rate-hike concerns
STORY: U.S. stocks rallied on Friday, with the Dow gaining more than a quarter of a percent, the S&P...
SPDR SSGA My2026 Municipal Bond ETF declares monthly distribution of $0.0699
SPDR SSGA My2034 Corporate Bond ETF declares monthly distribution of $0.1004
Pfizer's Stock Has Been a Dud Over the Past 5 Years, but Is It Still Worth Buying for Its 6.9% Yield?
The stock's yield is more than six times the S&P 500 average.
Israel’s defence minister triggers row after sacking general on TV
Opposition decries attempt by Israel Katz to oust commander responsible for West Bank as sop to far-right voters
All But 2 "Magnificent Seven" Stocks Are Underperforming the Market This Year. Here's 1 Company I'd Load Up On and 1 I'd Avoid
Both had similar issues, but one is much easier to justify because of its business direction.
Stock Market Today: Nasdaq Jumps 2% As Amazon Passes $3 Trillion Level; This Viking Tops Entry (Live Coverage)
Stock Market Today: The Dow Jones index jumps as Microsoft rallies. Oil stocks lag after Trump move on Iran. Amazon stock clears a milestone.
S&P 500 and Nasdaq climb 1%, Dow jumps 500 points on U.S.-Iran talks hopes
Wall Street jumps as oil tumbles 5% and Treasury yields retreat
SPDR SSGA My2032 Corporate Bond ETF declares monthly distribution of $0.0956
SPDR SSGA My2031 Corporate Bond ETF declares monthly distribution of $0.0933
SPDR SSGA My2030 Corporate Bond ETF declares monthly distribution of $0.0927
SPDR SSGA My2029 Corporate Bond ETF declares monthly distribution of $0.0933
Is NWL Stock a Buy as Low Valuation Meets Debt and Execution Risk?
Newell's discounted valuation, improving sales and margin recovery support the investment case, but debt and execution risks remain in focus.